Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.39 USD | +0.91% | +2.25% | +29.48% |
Sales 2024 * | 5.31B 416B | Sales 2025 * | 5.78B 454B | Capitalization | 8.7B 683B |
---|---|---|---|---|---|
Net income 2024 * | 414M 32.49B | Net income 2025 * | 464M 36.42B | EV / Sales 2024 * | 2.09 x |
Net Debt 2024 * | 2.42B 190B | Net Debt 2025 * | 2.14B 168B | EV / Sales 2025 * | 1.88 x |
P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
19.2
x | Employees | 27,209 |
Yield 2024 * |
0.69% | Yield 2025 * |
0.69% | Free-Float | 85.65% |
Latest transcript on Encompass Health Corporation
1 day | +0.91% | ||
1 week | +2.25% | ||
1 month | +3.61% | ||
3 months | +16.12% | ||
6 months | +32.56% | ||
Current year | +29.48% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 62 | 31/12/92 |
Douglas Coltharp
DFI | Director of Finance/CFO | 62 | 05/05/10 |
Chief Tech/Sci/R&D Officer | 64 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Leslye Katz
BRD | Director/Board Member | 69 | 24/01/13 |
Chairman | 62 | 31/12/19 | |
Director/Board Member | 68 | 30/09/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.44% | 8 M€ | -.--% | ||
1.39% | 2 M€ | -.--% | ||
1.09% | 231 M€ | -1.00% | ||
1.09% | 1 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 86.39 | +0.91% | 545,749 |
30/05/24 | 85.61 | +1.64% | 434,627 |
29/05/24 | 84.23 | +0.91% | 590,849 |
28/05/24 | 83.47 | -1.21% | 438,841 |
24/05/24 | 84.49 | -0.07% | 408,899 |
Delayed Quote Nyse, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.48% | 8.7B | |
-23.39% | 15.56B | |
-2.70% | 11.65B | |
+2.65% | 11.58B | |
+2.37% | 10.06B | |
-10.45% | 7.16B | |
+8.05% | 6.85B | |
-4.29% | 5.71B | |
+13.33% | 4.3B | |
-3.96% | 4.3B |
- Stock Market
- Equities
- EHC Stock